Stock RPHM RENEO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Real-time Estimate Cboe BZX
Other stock markets
 02:15:02 2024-05-01 pm EDT 		5-day change 1st Jan Change
1.715 USD +2.69% Intraday chart for Reneo Pharmaceuticals, Inc. +2.35% +7.47%
Mar. 28 Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 North American Morning Briefing : Tech in Focus on -2- DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
AQ
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
AQ
Women in Stem with Ashley Hall
AQ
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
GL
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
AQ
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
GL
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
AQ
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
AQ
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
GL
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
AQ
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
GL
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
AQ
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
GL
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RPHM Stock
  4. News Reneo Pharmaceuticals, Inc.
  5. Press Releases